Ledger.Open graph →
SEC Form D · filed September 8, 2022

Diasome Pharmaceuticals, Inc

Offering
$19.1M
Sold
$16.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CLEVELAND, OH
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

W. B. Geho · Cleveland, OHDirectorMarc B. Penn · Cleveland, OHDirectorThomas B. Mcdonald · Cleveland, OHDirectorRobert Geho · Cleveland, OHExec · Director · PromoterFrank B. Mccaney · Cleveland, OHDirectorMusheer Ahmed · Atlanta, GADirectorMichael Neril · Atlanta, GAExec · Director · PromoterCharles Russell · Spokane, WADirectorAhamad Mustaque · Atlanta, GADirectorRohit Pasam · Chicago, ILDirectorW. C. Grubb · Charlotte, NCDirectorJ.E. R. Taylor, Iii · Charlotte, NCDirectorTodd R. Williams · Charlotte, NCExec · Director · PromoterMichael Stubben · Las Vegas, NVDirectorMichael Ho · Miami, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗